Sildenafil delays the intestinal transit of a liquid meal in awake rats

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 1, 2008, Pages 78-81

  Graca J R V ^a   Macedo, G M ^a   Palheta, R C ^a   Gondim, F de A A ^a   Nogueira, R O ^a   Correia, J M ^a   Rola, R B ^a   Oliveira, R B ^b   Souza, M A N ^a   Santos, A A ^a  

^a Federal University of Ceará   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Intestinal transit; Mean arterial pressure; Scintigraphy; Sildenafil

Indexed keywords

SILDENAFIL; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL MOTILITY; IN VIVO STUDY; INTESTINAL DYSMOTILITY; INTESTINE TRANSIT TIME; ISOTOPE LABELING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; TEST MEAL;

RATTUS;

EID: 41149150675     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008000100012     Document Type: Article

References (20)

1. Gibson A. Phosphodiesterase 5 inhibitors and nitrergic transmission - from zaprinast to sildenafil. Eur J Pharmacol 2001; 411: 1-10.
2. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-1404.
3. Barreto AC, Franchi SM, Castro CR, Lopes AA. One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease. Braz J Med Biol Res 2005; 38: 185-195.
4. Santos CL, Souza MH, Gomes AS, Lemos HP, Santos AA, Cunha FQ, et al. Sildenafil prevents indomethacin-induced gastropathy in rats: role of leukocyte adherence and gastric blood flow. Br J Pharmacol 2005; 146: 481-486.
5. Zhang X, Tack J, Janssens J, Sifrim DA. Effect of sildenafil, a phosphodiesterase-5 inhibitor, on oesophageal peristalsis and lower oesophageal sphincter function in cats. Neurogastroenterol Motil 2001; 13: 325-331.
6. Sarnelli G, Sifrim D, Janssens J, Tack J. Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 2004; 287: G988-G992.
7. de Rosalmeida MC, Saraiva LD, da Graça JR, Ivo BB, da Nobrega MV, Gondim FA, et al. Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats. Dig Dis Sci 2003; 48: 2064-2068.
8. Araujo PV, Clemente CM, da Graça JR, Rola FH, de Oliveira RB, dos Santos AA, et al. Inhibitory effect of sildenafil on rat duodenal contractility in vitro: putative cGMP involvement. Clin Exp Pharmacol Physiol 2005; 32: 191-195.
9. Malagelada JR, Aspiroz F. Determinants of gastric emptying and transit in the small intestine. In: Wood JD (Editor), Handbook of physiology. The gastro-intestinal system. Section VI, Volume 1, Part 2. Bethesda: American Physiological Society; 1989. p 909-937.
10. Troncon LE, Santos AA, Garbacio VL, Secaf M, Verceze AV, Cunha-Melo JR. Inhibition of gastric emptying and intestinal transit in anesthetized rats by a Tityus serrulatus scorpion toxin. Braz J Med Biol Res 2000; 33: 1053-1058.
11. Miller MS, Galligan JJ, Burks TF. Accurate measurement of intestinal transit in the rat. J Pharmacol Methods 1981; 6: 211-217.
12. Lin HC, Prather C, Fisher RS, Meyer JH, Summers RW, Pimentel M, et al. Measurement of gastrointestinal transit. Dig Dis Sci 2005; 50: 989-1004.
13. Manara L, Bianchi G, Ferretti P, Tavani A. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther 1986; 237: 945-949.
14. Pol O, Valle L, Sanchez-Blazquez P, Garzon J, Puig MM. Antibodies and antisense oligodeoxynucleotides to mu-opioid receptors, selectively block the effects of mu-opioid agonists on intestinal transit and permeability in mice. Br J Pharmacol 1999; 127: 397-404.
15. Kaneda T, Yamamoto H, Azegami Y, Shimizu K, Urakawa N, Nakajyo S. Lack of cyclic nucleotide regulation of MBCQ-induced relaxation of rat ileal smooth muscle. J Smooth Muscle Res 2003; 39: 47-54.
16. Bortolotti M, Mari C, Lopilato C, La Rovere L, Miglioli M. Sildenafil inhibits gastroduodenal motility. Aliment Pharmacol Ther 2001; 15: 157-161.
17. Vobig MA. Retinal side-effects of sildenafil. Lancet 1999; 353: 1442.
18. Phillips BG, Kato M, Pesek CA, Winnicki M, Narkiewicz K, Davison D, et al. Sympathetic activation by sildenafil. Circulation 2000; 102: 3068-3073.
19. Gondim FA, de-Oliveira GR, Graça JR, Cavalcante DI, Souza MA, Santos AA, et al. Variations in gastric emptying of liquid elicited by acute blood volume changes in awake rats. Braz J Med Biol Res 1998; 31: 967-973.
20. Goldenberg MM. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction. Clin Ther 1998; 20: 1033-1048.